791012-39-0

Basic information

• Product Name: N-(2,4-dichlorobenzyl)piperidine-4-carboxamide
• Synonyms: N-(2,4-dichlorobenzyl)piperidine-4-carboxamide
• CAS NO: 791012-39-0
• Molecular Weight: 287.189
• Mol File: 791012-39-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: N-(2,4-dichlorobenzyl)piperidine-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2,4-dichlorobenzyl)piperidine-4-carboxamide(791012-39-0)
• EPA Substance Registry System: N-(2,4-dichlorobenzyl)piperidine-4-carboxamide(791012-39-0)

Safety Data

• Hazardous Substances Data: 791012-39-0(Hazardous Substances Data)

Upstream product

• 10314-99-5 benzyl 4-(chlorocarbonyl)piperidine-1-carboxylate 
• 95-00-1 2,4-dichloro-benzenemethanamine 
• 138163-07-2 piperidine-1,4-dicarboxylic acid 1-benzyl ester 4-methyl ester 
• 2971-79-1 isonipecotic acid methyl ester 
• 20781-20-8 2,4-Dimethoxybenzylamine 
• 6850-57-3 2-methoxybenzylamine 
• 73415-77-7 1-benzyloxycarbonyl-4-(N-2,4-dichlorobenzylcarbamoyl)piperidine 
• 1141894-77-0 1,1-dimethylethyl-4-({[(2,4-dichlorophenyl)methyl]amino}carbonyl)-1-piperidinecarboxylate 

Downstream Products

• 1155860-54-0 C₂₂H₂₀Cl₃N₃O₃S 
• 842965-16-6 C₁₈H₁₈Cl₂N₂O₂S 
• 1155860-59-5 C₂₃H₂₈Cl₂N₂O₃S 
• 1155860-37-9 C₃₂H₃₄Cl₄N₄O₆S₂ 
• 1155860-44-8 C₁₉H₁₈Cl₂FN₃O₅S 
• 1155860-45-9 C₂₂H₂₀BrCl₂N₃O₃S 
• 1155860-64-2 C₃₁H₄₄Cl₂N₂O₃S 
• 1155860-69-7 C₂₈H₃₅Cl₂N₃O₄S 
• 1155860-48-2 C₁₇H₁₇Cl₃N₂O₃S₂ 
• 1155860-41-5 C₁₇H₁₇BrCl₂N₂O₃S₂ 
• 1155860-39-1 C₂₂H₂₁Cl₂N₃O₃S 
• 1155860-50-6 C₁₆H₂₂Cl₂N₂O₃S 
• 1155860-43-7 C₁₅H₁₉Cl₃N₂O₃S 
• 1155860-47-1 C₁₉H₁₉Cl₂FN₂O₃S 

Relevant articles and documents

POTENT NON-UREA INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE

The present invention relates to compounds that exhibit vasodilatory and anti-inflammatory effects by inhibiting the activity of soluble epoxide hydrolase (sEH). The present invention is also directed to methods of identifying such compounds, and use of s

NOVEL sEH INHIBITORS AND THEIR USE

The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme. Specifically, the invention is directed to compounds according to Formula (I) wherein R1, R2, R3, R5a, R6a, A, B, K, L, M, Y, Z, I, an

NOVEL SEH INHIBITORS AND THEIR USE

The invention is directed to novel sEH inhibitors and their use in the treatment of diseases mediated by the sEH enzyme. Specifically, the invention is directed to compounds according to Formula (I): wherein R1, R2, R3, R5a, R6a, A, B, K, L, M, Y, Z, x, a